Evolving Approaches for the Management of Vasomotor Symptoms

Program at a Glance

Topics to be discussed:

  • Downfall of Menopausal Hormone Therapy (MHT) & the Impact on the Management of Vasomotor Symptoms
  • Limitations of Nonhormonal Pharmacotherapy: Consequences and Considerations
  • NK3 and NK1 Antagonism: Mechanism of Action and Considerations for Application
  • Holistic Approach to Address Menopausal Symptoms and Improve Quality of Life
  • Application to Clinical Practice — Integrating Neurokinin Inhibitors and Holistic Care into the Current Clinical Setting

program overview